Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort

Diabetologia

Volumn 58, Issue 5, 2015, Pages 1109-1117

  Cederberg, Henna ^a   Stančáková, Alena ^a   Yaluri, Nagendra ^a   Modi, Shalem ^a   Kuusisto, Johanna ^a   Laakso, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

2 h glucose; Fasting glucose; HbA1c; Insulin resistance; Insulin sensitivity; Statin; Type 2 diabetes

Indexed keywords

GLUCOSE BLOOD LEVEL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

AGED; BLOOD; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RISK; SECRETION (PROCESS);

AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK;

EID: 84939969799     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3528-5     Document Type: Article

References (28)

1. Cholesterol Treatment Trialists (CTT) Collaborators, Kearney PM, Blackwell L et al (2008) Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371:117–125
2. Cholesterol Treatment Trialists (CTT) Collaborators, Baigent C, Blackwell L et al (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376:1670–1681
3. Freeman DJ, Norrie J, Sattar N et al (2001) Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 103:357–362
4. Ridker PM, Danielson E, Fonseca FA et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195–2207
5. Culver AL, Ockene IS, Balasubramanian R et al (2012) Statin use and risk of diabetes mellitus in postmenopausal women in the Women’s Health Initiative. Arch Intern Med 172:144–152
6. Rajpathak SN, Kumbhani DJ, Crandall J, Barzilai N, Alderman M, Ridker PM (2009) Statin therapy and risk of developing type 2 diabetes: a meta-analysis. Diabetes Care 32:1924–1929
7. Waters DD, Ho JE, DeMicco DA et al (2011) Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J Am Coll Cardiol 57:1535–1545
8. Sattar N, Preiss D, Murray HM et al (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375:735–742
9. Preiss D, Seshasai SR, Welsh P et al (2011) Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 305:2556–2564
10. Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM (2013) Risk of incident diabetes among patients treated with statins: population based study. BMJ 346:f2610
11. Wang KL, Liu CJ, Chao TF et al (2012) Statins, risk of diabetes, and implications on outcomes in the general population. J Am Coll Cardiol 60:1231–1238
12. Zaharan NL, Williams D, Bennett K (2013) Statins and risk of treated incident diabetes in a primary care population. Br J Clin Pharmacol 75:1118–1124
13. Sattar N, Taskinen MR (2012) Statins are diabetogenic–myth or reality? Atheroscler Suppl 13:1–10
14. Altunbas H, Balci MK, Karayalcin U (2003) No effect of simvastatin treatment on insulin sensitivity in patients with primary hypercholesterolemia. Endocr Res 29:265–275
15. Bellia A, Rizza S, Galli A, Fabiano R, Donadel G, Lombardo MF (2010) Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes. Atherosclerosis 210:199–201
16. Paniagua JA, Lopez-Miranda J, Escribano A et al (2002) Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes. Diabetes 51:2596–2603
17. Szendroedi J, Anderwald C, Krssak M et al (2009) Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients. Diabetes Care 32:209–214
18. ter Avest E, Abbink EJ, de Graaf J, Tack CJ, Stalenhoef AF (2005) Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia. Eur J Clin Investig 35:558–564
19. Baker WL, Talati R, White CM, Coleman CI (2010) Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis. Diabetes Res Clin Pract 87:98–107
20. Moutzouri E, Liberopoulos E, Mikhailidis DP et al (2011) Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance. Int J Clin Pract 65:1141–1148
21. 2+ channels in rat islet β-cells. Br J Pharmacol 126:1205–1213
22. Ishikawa M, Okajima F, Inoue N et al (2006) Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells. J Atheroscler Thromb 13:329–335
23. Stancakova A, Javorsky M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M (2009) Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 58:1212–1221
24. American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29(Suppl 1):S43–S48
25. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470
26. Sukhija R, Prayaga S, Marashdeh M et al (2009) Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients. J Investig Med 57:495–499
27. Rautio N, Jokelainen J, Oksa H et al (2012) Do statins interfere with lifestyle intervention in the prevention of diabetes in primary healthcare? One-year follow-up of the FIN-D2D project. BMJ Open 2:e001472
28. Navarese EP, Buffon A, Andreotti F et al (2013) Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol 111:1123–1130